GSK-115616

Study Sponsor: GSK

Study Title

Efficacy of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 against TB disease, in adults living in a TB endemic region

Medicine or Vaccine (generic name)

SB692342

Sponsor Identification Number

115616

Trial Registry Identification Number(#'s)

NCT01755598

Medical Condition

Tuberculosis

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

There is a Publicaton Steering Committee for this study.

Date Added to this Site

October 2019